<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03094546</url>
  </required_header>
  <id_info>
    <org_study_id>SmartAge</org_study_id>
    <nct_id>NCT03094546</nct_id>
  </id_info>
  <brief_title>Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline</brief_title>
  <acronym>SmartAge</acronym>
  <official_title>Effect of Polyamine-enriched Dietary Supplementation on Cognitive Function and Biomarkers in Elderly Individuals With Subjective Cognitive Decline</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Freie Universität, Institute of Biology/Genetic, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karl-Fransens-Universität, Institute of Molecular Biosciences, Graz, Austria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to examine the effect of polyamine supplementation on
      cognitive performance and further characterization of individuals with subjective cognitive
      decline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Memory abilities are known to decline during aging, a process that is accelerated in
      pathological conditions like mild cognitive impairment (MCI) and Alzheimer's disease (AD),
      all of which are a growing public-health concern with devastating social and economical
      effects. Polyamines supplementation and corresponding up-regulation of autophagy (i.e.,
      cellular protein degradation pathways) may be a key target of intervention against
      age-related memory decline. The study will investigate whether a polyamine-enriched dietary
      supplementation (through capsule intake) could provide positive effects on cognitive function
      and biomarkers of elderly individuals (60-90 years old) with subjective cognitive decline
      (SCD).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Memory performance from neuropsychological test</measure>
    <time_frame>change from baseline after 12 month (Prior to intervention (baseline T0) and after 12 months)</time_frame>
    <description>Comparing memory function in subjects with polyamine intake and placebo treatment assessed prior to intervention (pre) vs. 12 month post intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Cognitive Function (from extended neuropsychological test battery)</measure>
    <time_frame>change from baseline after 12 month</time_frame>
    <description>Comparing cognitive function in subjects with polyamine intake and placebo treatment assessed prior to intervention (pre) vs. 12 month post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in polyamine concentration</measure>
    <time_frame>change from baseline after 12 month</time_frame>
    <description>comparing polyamine concentration derived from blood plasma assessed prior to intervention (pre) vs. 12 month post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in inflammation</measure>
    <time_frame>change from baseline after 12 month</time_frame>
    <description>comparing inflammation markers derived from blood plasma assessed prior to intervention (pre) vs. 12 month post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Brain imaging biomarkers</measure>
    <time_frame>change from baseline after 12 month</time_frame>
    <description>Multimodal analysis of biomarkers, regarding structural, functional, and perfusion-related plasticity, derived from magnet resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Autophagy processes</measure>
    <time_frame>change from baseline after 12 month</time_frame>
    <description>Evaluate autophagy processes through muscle biopsy assessed prior to intervention (pre) vs. 12 month post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Autophagy processes</measure>
    <time_frame>change from baseline after 12 month</time_frame>
    <description>Evaluate autophagy processes through blood parameters assessed prior to intervention (pre) vs. 12 month post intervention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Subjective Cognitive Decline (SCD)</condition>
  <arm_group>
    <arm_group_label>Polyamine supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Dietary Supplement (Polyamine supplementation):</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intervention: Dietary Supplement Placebo:</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Polyamine</intervention_name>
    <description>12 months of polyamine supplementation (6 capsules/day)</description>
    <arm_group_label>Polyamine supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>12 months of placebo intake (6 capsules/day)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cognitive healthy individuals with subjective memory decline and self-reported
             concerns

          -  60-90 years old

          -  No manifest dementia (DSM-IV criteria)

          -  No limitations in activities of daily living

          -  Capacity for consent

        Exclusion Criteria:

          -  Gluten, histamine or wheat seedling intolerance

          -  Severe neurological, internal or psychological diseases

          -  Advanced heart or respiratory diseases, severe arteriosclerosis, untreated thyroid
             disease or diabetes

          -  Malignant tumors, current or past history

          -  Brain tumors, stroke

          -  Disorders that impair attention

          -  Dementia

          -  Coagulation disorder, Marcumar

          -  Drug abuse or alcohol dependency

          -  Current polyamine substitution
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Agnes Floeel, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité - Universitätsmedizin Berlin, Greifswald Universitätsmedizin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dietmar Schmitz, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gloria Benson, Graduate</last_name>
    <phone>+49 30/450 660 223</phone>
    <email>gloria.benson@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Miranka Wirth, Graduate</last_name>
    <phone>+49 30/ 450 560 185</phone>
    <email>miranka.wirth@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charité University Medicine Berlin, CCM, Department of Neurology,</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gloria Benson, Graduate</last_name>
      <email>gloria.benson@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Claudia Schwarz, Graduate</last_name>
      <email>claudia.schwarz@charite.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Eisenberg T, Knauer H, Schauer A, Büttner S, Ruckenstuhl C, Carmona-Gutierrez D, Ring J, Schroeder S, Magnes C, Antonacci L, Fussi H, Deszcz L, Hartl R, Schraml E, Criollo A, Megalou E, Weiskopf D, Laun P, Heeren G, Breitenbach M, Grubeck-Loebenstein B, Herker E, Fahrenkrog B, Fröhlich KU, Sinner F, Tavernarakis N, Minois N, Kroemer G, Madeo F. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009 Nov;11(11):1305-14. doi: 10.1038/ncb1975. Epub 2009 Oct 4.</citation>
    <PMID>19801973</PMID>
  </reference>
  <reference>
    <citation>Gupta VK, Scheunemann L, Eisenberg T, Mertel S, Bhukel A, Koemans TS, Kramer JM, Liu KS, Schroeder S, Stunnenberg HG, Sinner F, Magnes C, Pieber TR, Dipt S, Fiala A, Schenck A, Schwaerzel M, Madeo F, Sigrist SJ. Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner. Nat Neurosci. 2013 Oct;16(10):1453-60. doi: 10.1038/nn.3512. Epub 2013 Sep 1.</citation>
    <PMID>23995066</PMID>
  </reference>
  <reference>
    <citation>Ibe S, Kumada K, Yoshida K, Otobe K. Natto (fermented soybean) extract extends the adult lifespan of Caenorhabditis elegans. Biosci Biotechnol Biochem. 2013;77(2):392-4. Epub 2013 Feb 7.</citation>
    <PMID>23391920</PMID>
  </reference>
  <reference>
    <citation>Minois N, Carmona-Gutierrez D, Madeo F. Polyamines in aging and disease. Aging (Albany NY). 2011 Aug;3(8):716-32. Review.</citation>
    <PMID>21869457</PMID>
  </reference>
  <reference>
    <citation>Schaeffer V, Lavenir I, Ozcelik S, Tolnay M, Winkler DT, Goedert M. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain. 2012 Jul;135(Pt 7):2169-77. doi: 10.1093/brain/aws143. Epub 2012 Jun 10.</citation>
    <PMID>22689910</PMID>
  </reference>
  <reference>
    <citation>Soda K, Dobashi Y, Kano Y, Tsujinaka S, Konishi F. Polyamine-rich food decreases age-associated pathology and mortality in aged mice. Exp Gerontol. 2009 Nov;44(11):727-32. doi: 10.1016/j.exger.2009.08.013. Epub 2009 Sep 6.</citation>
    <PMID>19735716</PMID>
  </reference>
  <reference>
    <citation>Soda K, Kano Y, Sakuragi M, Takao K, Lefor A, Konishi F. Long-term oral polyamine intake increases blood polyamine concentrations. J Nutr Sci Vitaminol (Tokyo). 2009 Aug;55(4):361-6.</citation>
    <PMID>19763038</PMID>
  </reference>
  <reference>
    <citation>Tiboldi A, Lentini A, Provenzano B, Tabolacci C, Höger H, Beninati S, Lubec G. Hippocampal polyamine levels and transglutaminase activity are paralleling spatial memory retrieval in the C57BL/6J mouse. Hippocampus. 2012 May;22(5):1068-74. doi: 10.1002/hipo.22016. Epub 2012 Mar 30.</citation>
    <PMID>22467251</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>March 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2017</study_first_posted>
  <last_update_submitted>March 29, 2017</last_update_submitted>
  <last_update_submitted_qc>March 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Agnes Flöel</investigator_full_name>
    <investigator_title>Prof. Agnes Flöel, MD;</investigator_title>
  </responsible_party>
  <keyword>subjective cognitive decline</keyword>
  <keyword>Alzheimer's disease, dementia</keyword>
  <keyword>dietary supplement</keyword>
  <keyword>polyamine</keyword>
  <keyword>prevention</keyword>
  <keyword>treatment</keyword>
  <keyword>lifestyle</keyword>
  <keyword>memory</keyword>
  <keyword>autophagy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

